| Literature DB >> 26902928 |
Kai-Zhi Jia1, Quan Zhang1, Lin-Yang Sun1, Yang-Hua Xu1, Hong-Mei Li1, Ya-Jie Tang1.
Abstract
Eukaryote-derived methioninase, catalyzing the one-step degradation of methionine (Met) to methanethiol (MTL), has received much attention for its low immunogenic potential and use as a therapeutic agent against Met-dependent tumors. Although biological and chemical degradation pathways for Met-MTL conversion are proposed, the concrete molecular mechanism for Met-MTL conversion in eukaryotes is still unclear. Previous studies demonstrated that α-keto-methylthiobutyric acid (KMBA), the intermediate for Met-MTL conversion, was located extracellularly and the demethiolase STR3 possessed no activities towards Met, which rule out the possibility of intracellular Met-MTL conversion pathway inside eukaryotes. We report here that degradation of Met resulted in intracellular accumulation of KMBA in Clonostachys rosea. Addition of Met to culture media led to the production of MTL and downregulation of STR3, while incubation of Met with surrogate substrate α-ketoglutaric acid enhanced the synthesis of MTL and triggered the upregulation of STR3. Subsequent biochemical analysis with recombinant STR3 showed that STR3 directly converted both Met and its transamination product KMBA to MTL. These results indicated that STR3 as rate-limiting enzyme degrades Met and KMBA into MTL. Our findings suggest STR3 is a potential target for therapeutic agents against Met-dependent tumors and aging.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26902928 PMCID: PMC4763297 DOI: 10.1038/srep21920
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Intracellular KMBA was identified by LC-MS.
(A) LC-MS analysis of standard KMBA, (B) LC-MS analysis of intracellular KMBA.
Figure 2KMBA was located exclusively intracellularly in C. rosea.
(●intracellular KMBA, ○extracellular KMBA).
Primers for gene cloning and expression.
| Genes | Primers | Sequence |
|---|---|---|
| Homology-based cloning | ||
| AAT1-5F | 5′-ATHAAYYTNGGNGTNGGNGCNTA-3′ | |
| AAT1-3R | 5′-NARNCCNGTRTANGCRAACAT-3′ | |
| AAT1-3R-22 | 5′-CCCATRTTYTTNGCRAANSWYTG-3′ | |
| AAT2-5F | 5′-YTNGGNATHGGNGCNTAGMGNGA-3′ | |
| AAT2-3R | 5′-DATNCKNCCNSWCATHGTNC-3′ | |
| AAT2-5F-22 | 5′-CAYGCNTGYGCNCAYAAYCCNAC-3′ | |
| AAT2-3R-22 | 5′-GGNGGRTTNSWDATYTCNSWNC-3′ | |
| ARO8-5F2 | 5′-ATHWSNYTNGGNGGNGGNYTNCC-3′ | |
| ARO8-3R-23 | 5′-RAACCANSWNCCNCKNGCNAC-3′ | |
| ARO8-4R | 5′-RTARTANGGYTCRTCYTCDATDAT-3′ | |
| BAT-5F1 | 5′-TAYGCNACNGARTGYTTYGARGG-3′ | |
| BAT-3R1 | 5′-RTCNARNGGNGCNGTDATNA-3′ | |
| BAT-5F2 | 5′-GNAARYTNMGNYTNTTYMGNCC-3′ | |
| BAT-3R2 | 5′-RTARTTNGCNCCNACYTT-3′ | |
| STR3-5F | 5′-MGNWSNGGNAAYCCNACNMG | |
| STR3-3R | 5′-ARNSWRTTNACRCANCCRAA-3′ | |
| STR3-3R2 | 5′-NCCNGTYTCRAANSWNARNACNGC-3′ | |
| Full-length cDNA cloning | ||
| AAT1-3RA1 | 5′-CCCTCGACAGGCTCGCCATTACCCAG-3′ | |
| AAT1-3NRA2 | 5′-GTGCTGAGTTCCTTCAGCGCTGGTACAG-3′ | |
| AAT1-5RA1 | 5′-CACTGGTCCTGGCTGGGGTCAACA-3′ | |
| AAT1-5NRA2 | 5′-GAGGAGTGTTCTTGAGGTCCTCAACCAG-3′ | |
| AAT2-3RA1 | 5′-GAGCTGCTCATCGCCCAGAGCTTC-3′ | |
| AAT2-3NRA2 | 5′-GTGCTGGCTGCTTCCACGCCATCACCTC-3′ | |
| AAT2-5RA1 | 5′-CTCACTCATTAGGCACCCCAGGC-3′ | |
| AAT2-5NRA2 | 5′-CACAGGAAACAGCTATGACCATGATTAC-3′ | |
| ARO8-3RA1 | 5′-TGACCTCTCCATCGCCCTCAACTAC-3′ | |
| ARO8-3NRA2 | 5′-GAACACACCGAGCTGGTCTGCCGCCCTC-3′ | |
| ARO8-5RA1 | 5′-TCGTCCATTGCCTCGGGGATGAGTC-3′ | |
| ARO8-5NRA2 | 5′-GAACATGTTGATTCCAAGAGGGGCGAATG-3′ | |
| ARO8-23RA1 | 5′-AGCTCCATGCAGCAGCGAGACCTTC-3′ | |
| ARO8-23NRA2 | 5′-CCAGCCGGACTGGCTCATCCCTCAAGGGTG-3′ | |
| ARO8-25RA1 | 5′-AGCGCAGAAGCTGGGCTGAGCCAC-3′ | |
| ARO8-25NRA2 | 5′-CACTCTGGCCGTCTCGGAGATCGTGCTTG-3′ | |
| BAT-3RA1 | 5′-GAGCAGCGCGGATACTCCCTCTAC-3′ | |
| BAT-3NRA2 | 5′-CCAGGCTCAGCCCTCCTCTATGTTATTG-3′ | |
| BAT-5RA1 | 5′-GTGACGTACTGCTCCTCGCCGAAG-3′ | |
| BAT-5NRA2 | 5′-CAGGTTCTGCTGGTGGCCCCTGGAGCTG-3′ | |
| STR3-3RA1 | 5′-TCCTCGAAACACCTACAAACCCTC-3′ | |
| STR3-3NRA2 | 5′-CCAACAATCGCCCGGAATGCCCACGAAG-3′ | |
| STR3-5RA1 | 5′-GAATGGCAAGAGTCTTGACTCCTC-3′ | |
| STR3-5NRA2 | 5′-TCATTGGGTGACAGACCGCAGCCAGTTG-3′ | |
| YSTR3-5H | 5′-CCC | |
| YSTR3-3BH | 5′-CGC | |
| F5 | 5′-AGTATCAACAAAAAATTGTTA-3′ | |
| R3 | 5′-GAATGTAAGCGTGACATAACTAA-3′ | |
The restriction enzyme sites are underlined, and the His-tag encoding sequences are in bold.
Figure 3Role of ARO8-2, BAT and STR3 in Met-MTL conversion.
(A) Met-MTL conversion pathway genes obtained by homology-based cloning, (B) Transcriptional analysis of putative pathway genes (Normalized fold expression values for synthase genes were relative to the control without Met addition. The error type was standard deviation).
Figure 4Functional analyses of STR3 in Met-MTL conversion.
(A–D) Effect of α-KG addition on the production of KMBA (A), MTL (B), DMS (C) and DMTS (D) (■The addition of α-KG with Met, ●The addition of Met, □The addition of α-KG, ○Control), (E,F) Effect of α-KG addition on transcriptional expression of Met-MTL conversion pathway genes on days 3 (E) and 5 (F) (Normalized fold expression values for synthase genes were relative to the control without Met addition. The error type was standard deviation).
Figure 5Functional analyses of STR3 in vitro.
(A) SDS-PAGE of purified STR3, SEC: size exclusion chromatography; (B) Partial sequence alignment of STR3 with other demethiolases. Number is provided for aCBL, the catalytic residues (Y181, D253, K278), binding sites related to PLP (Y127, R129, G157, M158, T277), substrate binding sites (D126, G182, N307, V404, F406) in aCBL are indicated, STR3-C.r: C. rosea STR3(KT157524), STR3-S.c: S. cerevisiae STR3 (EDZ72299), CBL-A: Arabidopsis CBL (NP_191264).
Effect of cofactor PLP levels on STR3 activity.
| Molar ratio (PLP/STR3) | Relative activity (%) |
|---|---|
| 0 | 100 |
| 0.5 | 132.6 ± 1.7 |
| 1 | 137.4 ± 2.5 |
| 2 | 140.7 ± 2.8 |
Specific activity toward KMBA was 0.53 ± 0.0030 μM MTL·h−1·mg protein−1. The relative activity of demethiolation of KMBA to MTL was set at 100%.
Substrate specificity of purified STR3.
Demethiolation activities with different substrates were determined in the standard enzyme assay system. Specific activity toward L-cystathionine was 22.04 ± 2.40 mM MTL·min−1·mg protein−1. The relative activity of demethiolation of L-cystathionine to thiol was set at 100%.
Figure 6The Met-MTL conversion pathway proposed in the present study.
The blue marks indicate proposed functions of STR3 in the present study. After Met addition, KMBA as a Met degradation intermediate was localized intracellularly; BAT and ARO8-2 are activated, but STR3 was repressed accompanied with MTL production; STR3 catalyzes direct conversion of Met and its transaminated product KMBA into MTL. VOSCs: volatile organic sulfur-containing compounds including 3-(methylthio)propanal, 3-(methylthio)propanol and MTL, DMS, DMTS.